150 related articles for article (PubMed ID: 35857053)
1. Juvenile xanthogranuloma in neurofibromatosis type 1. Prevalence and possible correlation with lymphoproliferative diseases: experience of a single center and review of the literature.
Miraglia E; Laghi A; Moramarco A; Giustini S
Clin Ter; 2022; 173(4):353-355. PubMed ID: 35857053
[TBL] [Abstract][Full Text] [Related]
2. Association Between Juvenile Myelomonocytic Leukemia, Juvenile Xanthogranulomas and Neurofibromatosis Type 1: Case Report and Review of the Literature.
Paulus S; Koronowska S; Fölster-Holst R
Pediatr Dermatol; 2017 Mar; 34(2):114-118. PubMed ID: 28111791
[TBL] [Abstract][Full Text] [Related]
3. Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia.
Raygada M; Arthur DC; Wayne AS; Rennert OM; Toretsky JA; Stratakis CA
Pediatr Blood Cancer; 2010 Jan; 54(1):173-5. PubMed ID: 19785027
[TBL] [Abstract][Full Text] [Related]
4. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis.
Zvulunov A; Barak Y; Metzker A
Arch Dermatol; 1995 Aug; 131(8):904-8. PubMed ID: 7632061
[TBL] [Abstract][Full Text] [Related]
5. Penile juvenile xanthogranuloma and neurofibromatosis type-1: risk association with juvenile myelomonocytic leukaemia?
AlGhamdi KM; Al Suwaidan SN
East Mediterr Health J; 2010 Apr; 16(4):451-4. PubMed ID: 20795434
[No Abstract] [Full Text] [Related]
6. Neurofibromatosis type 1 diagnosed in a child based on multiple juvenile xanthogranulomas and juvenile myelomonocytic leukemia.
Jans SR; Schomerus E; Bygum A
Pediatr Dermatol; 2015; 32(1):e29-32. PubMed ID: 25516272
[TBL] [Abstract][Full Text] [Related]
7. Juvenile xanthogranuloma associated with neurofibromatosis 1: 14 patients without evidence of hematologic malignancies.
Cambiaghi S; Restano L; Caputo R
Pediatr Dermatol; 2004; 21(2):97-101. PubMed ID: 15078345
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study.
García-Martínez FJ; Duat-Rodríguez A; Andrés Esteban E; Torrelo A; Noguera Morel L; Hernández-Martín A
Actas Dermosifiliogr; 2022; 113(10):T923-T929. PubMed ID: 36162491
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study.
García-Martínez FJ; Duat-Rodríguez A; Andrés Esteban E; Torrelo A; Noguera Morel L; Hernández-Martín A
Actas Dermosifiliogr; 2022; 113(10):923-929. PubMed ID: 35636506
[TBL] [Abstract][Full Text] [Related]
10. JXG, NF1, and JMML: alphabet soup or a clinical issue?
Burgdorf WH; Zelger B
Pediatr Dermatol; 2004; 21(2):174-6. PubMed ID: 15078363
[No Abstract] [Full Text] [Related]
11. Juvenile myelomonocytic leukemia presenting with features of hemophagocytic lymphohistiocytosis in association with neurofibromatosis and juvenile xanthogranulomas.
Shin HT; Harris MB; Orlow SJ
J Pediatr Hematol Oncol; 2004 Sep; 26(9):591-5. PubMed ID: 15342987
[TBL] [Abstract][Full Text] [Related]
12. The relationship between neurofibromatosis type 1, juvenile xanthogranuloma, and malignancy: A retrospective case-control study.
Liy-Wong C; Mohammed J; Carleton A; Pope E; Parkin P; Lara-Corrales I
J Am Acad Dermatol; 2017 Jun; 76(6):1084-1087. PubMed ID: 28189268
[TBL] [Abstract][Full Text] [Related]
13. Juvenile xanthogranuloma and neurofibromatosis 1.
Tan HH; Tay YK
Dermatology; 1998; 197(1):43-4. PubMed ID: 9693184
[TBL] [Abstract][Full Text] [Related]
14. Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1.
Ferrari F; Masurel A; Olivier-Faivre L; Vabres P
JAMA Dermatol; 2014 Jan; 150(1):42-6. PubMed ID: 24258576
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous manifestations in neurofibromatosis type 1.
Miraglia E; Moliterni E; Iacovino C; Roberti V; Laghi A; Moramarco A; Giustini S
Clin Ter; 2020; 171(5):e371-e377. PubMed ID: 32901776
[TBL] [Abstract][Full Text] [Related]
16. Juvenile xanthogranulomas in Asian children.
Wee LWY; Ling HY; Ho VPY; Foong AYW; Koh MJA
Dermatol Ther; 2022 Feb; 35(2):e15224. PubMed ID: 34820973
[TBL] [Abstract][Full Text] [Related]
17. Update on juvenile xanthogranuloma: unusual cutaneous and systemic variants.
Chang MW
Semin Cutan Med Surg; 1999 Sep; 18(3):195-205. PubMed ID: 10468039
[TBL] [Abstract][Full Text] [Related]
18. [Juvenile myelomonocytic leukaemia, xanthoma, and neurofibromatosis type 1].
Benessahraoui M; Aubin F; Paratte F; Plouvier E; Humbert P
Arch Pediatr; 2003 Oct; 10(10):891-4. PubMed ID: 14550978
[TBL] [Abstract][Full Text] [Related]
19. Juvenile xanthogranuloma: A possible diagnostic criterion for Neurofibromatosis type 1 in young children.
Calligaris L; Cortellazzo Wiel L; Sartor E; Berti I; Bruno I; Barbi E; Magnolato A
Am J Med Genet A; 2021 Dec; 185(12):3895-3896. PubMed ID: 34250743
[No Abstract] [Full Text] [Related]
20. [Juvenile xanthogranulomas associated with neurofibromatosis type 1].
Godoy Gijón E; Yuste Chaves M; Sáez Martín LC
An Pediatr (Barc); 2012 Apr; 76(4):230-1. PubMed ID: 22015054
[No Abstract] [Full Text] [Related]
[Next] [New Search]
